|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
Document/Exhibit Description Pages Size
1: T-3/A Pre-Effective Amendment to Application for a HTML 171K
Qualification of a Trust Indenture
2: EX-99.T3B-1 Exhibit T3B-1 HTML 625K
11: EX-99.T3B-10 Exhibit T3B-10 HTML 69K
12: EX-99.T3B-11 Exhibit T3B-11 HTML 66K
13: EX-99.T3B-12 Exhibit T3B-12 HTML 67K
14: EX-99.T3B-13 Exhibit T3B-13 HTML 70K
15: EX-99.T3B-14 Exhibit T3B-14 HTML 83K
16: EX-99.T3B-15 Exhibit T3B-15 HTML 74K
17: EX-99.T3B-16 Exhibit T3B-16 HTML 70K
18: EX-99.T3B-17 Exhibit T3B-17 HTML 76K
19: EX-99.T3B-18 Exhibit T3B-18 HTML 70K
20: EX-99.T3B-19 Exhibit T3B-19 HTML 75K
3: EX-99.T3B-2 Exhibit T3B-2 HTML 81K
21: EX-99.T3B-20 Exhibit T3B-20 HTML 70K
22: EX-99.T3B-21 Exhibit T3B-21 HTML 75K
23: EX-99.T3B-22 Exhibit T3B-22 HTML 64K
24: EX-99.T3B-23 Exhibit T3B-23 HTML 65K
25: EX-99.T3B-24 Exhibit T3B-24 HTML 82K
26: EX-99.T3B-25 Exhibit T3B-25 HTML 65K
27: EX-99.T3B-26 Exhibit T3B-26 HTML 49K
28: EX-99.T3B-27 Exhibit T3B-27 HTML 45K
29: EX-99.T3B-28 Exhibit T3B-28 HTML 68K
30: EX-99.T3B-29 Exhibit T3B-29 HTML 67K
4: EX-99.T3B-3 Exhibit T3B-3 HTML 71K
31: EX-99.T3B-30 Exhibit T3B-30 HTML 49K
32: EX-99.T3B-31 Exhibit T3B-31 HTML 54K
33: EX-99.T3B-32 Exhibit T3B-32 HTML 68K
34: EX-99.T3B-33 Exhibit T3B-33 HTML 68K
35: EX-99.T3B-34 Exhibit T3B-34 HTML 65K
36: EX-99.T3B-35 Exhibit T3B-35 HTML 63K
37: EX-99.T3B-36 Exhibit T3B-36 HTML 67K
38: EX-99.T3B-37 Exhibit T3B-37 HTML 51K
39: EX-99.T3B-38 Exhibit T3B-38 HTML 281K
40: EX-99.T3B-39 Exhibit T3B-39 HTML 48K
5: EX-99.T3B-4 Exhibit T3B-4 HTML 67K
41: EX-99.T3B-40 Exhibit T3B-40 HTML 52K
42: EX-99.T3B-41 Exhibit T3B-41 HTML 43K
43: EX-99.T3B-42 Exhibit T3B-42 HTML 46K
44: EX-99.T3B-43 Exhibit T3B-43 HTML 46K
45: EX-99.T3B-44 Exhibit T3B-44 HTML 66K
46: EX-99.T3B-45 Exhibit T3B-45 HTML 46K
47: EX-99.T3B-46 Exhibit T3B-46 HTML 46K
48: EX-99.T3B-47 Exhibit T3B-47 HTML 44K
49: EX-99.T3B-48 Exhibit T3B-48 HTML 47K
50: EX-99.T3B-49 Exhibit T3B-49 HTML 47K
6: EX-99.T3B-5 Exhibit T3B-5 HTML 67K
51: EX-99.T3B-50 Exhibit T3B-50 HTML 45K
52: EX-99.T3B-51 Exhibit T3B-51 HTML 44K
53: EX-99.T3B-52 Exhibit T3B-52 HTML 47K
54: EX-99.T3B-53 Exhibit T3B-53 HTML 154K
55: EX-99.T3B-54 Exhibit T3B-54 HTML 32K
56: EX-99.T3B-55 Exhibit T3B-55 HTML 159K
57: EX-99.T3B-56 Exhibit T3B-56 HTML 67K
58: EX-99.T3B-57 Exhibit T3B-57 HTML 50K
59: EX-99.T3B-58 Exhibit T3B-58 HTML 51K
7: EX-99.T3B-6 Exhibit T3B-6 HTML 48K
8: EX-99.T3B-7 Exhibit T3B-7 HTML 66K
9: EX-99.T3B-8 Exhibit T3B-8 HTML 49K
10: EX-99.T3B-9 Exhibit T3B-9 HTML 68K
60: EX-99.T3C Exhibit T3C HTML 1.15M
61: EX-99.T3D-1 Exhibit T3D-1 HTML 72K
62: EX-99.T3E-1 Exhibit T3E-1 HTML 117K
63: EX-99.T3E-2 Exhibit T3E-2 HTML 43K
64: EX-99.T3E-3 Exhibit T3E-3 HTML 4.16M
Exhibit T3B-54
AMENDMENT NO. 1 TO THE AMENDED AND RESTATED
BY-LAWS
OF SIRA NATURALS, INC.
This Amendment No. 1 (the “Amendment”) to the Amended and Restated By-Laws (the “By-Laws”) of Sira Naturals, Inc. (the “Company”) is made as of May 24, 2019 (the “Effective Date”).
WHEREAS, Article II, Section 2 of the By-Laws provides that the number of directors constituting the Company’s Board of Directors is fixed as five (5);
WHEREAS, pursuant to Article IX, Section 1 of the By-Laws and Section 6.3 of the Company’s Articles of Entity Conversion of a Domestic Non-Profit with a Pending Provisional or Final Certification to Dispense Medical Use Marijuana to a Domestic Business Corporation, the Board of Directors of the Company has the power to amend Article II, Section 2 of the By-Laws;
WHEREAS, the Board desires to amend Article II, Section 2 of the By-Laws in its entirety as set forth in this Amendment.
NOW THEREFORE, it is hereby agreed as follows:
1. Article II, Section 2 of the By-Laws is hereby amended by striking and deleting such Section in its entirety and replacing it with the following in lieu thereof:
“Section 2. Number and Election. The Board of Directors shall consist of one or more individuals with the number fixed by the vote or written consent of the shareholders or the Board of Directors. Except as otherwise provided in these By-Laws or the Articles of Organization (or similar document), the Directors shall be elected by the shareholders.”
2. Except as amended hereby, the By-Laws shall remain in full force and effect in accordance with its terms.
[Remainder of page intentionally left blank]
Executed as an instrument under seal as of the Effective Date.
| SIRA NATURALS, INC. | ||
| By: | /s/ Michael Dundas | |
| Michael Dundas | ||
| President | ||
[Signature Page to Amendment No. 1 to Amended and Restated By-Laws of Sira Naturals, Inc.]
| This ‘T-3/A’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 11/22/23 | None on these Dates | ||
| 5/24/19 | ||||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/30/24 Ayr Wellness Inc. T-3/A 3:717K Toppan Merrill/FA |